R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
| Title | Location |
Date
|
Req ID | |
|---|---|---|---|---|
|
Manager, Americas Regulatory Affairs Labeling & Promotion, Global Rare Diseases
Cary, NC, US
Jul 17, 2026
7526
|
||||
|
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Europe, IT
Jul 11, 2026
6111
|
||||
|
Specialist, Labelling & Compliance Regulatory Affairs, Global Rare Diseases
Parma, IT
Jul 11, 2026
7364
|
||||
|
Specialist Care Therapeutic Area, Global Regulatory Affairs and Patient Safety - Temporary
Paris, Bois Colombes, FR
Jul 7, 2026
7450
|
||||